CDEK
← All drugs Report issue

mr-107a-01

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
2
Phase 4
0

Earliest trial started Sep 29, 2020 (NCT04571515)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06215820Phase 3Dec 29, 2023Mylan, Viatris
NCT06215859Phase 3Dec 29, 2023Mylan, Viatris
NCT05317312Phase 2Mar 31, 2022Mylan
NCT04571515Phase 2Sep 29, 2020Mylan
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MylanFor profit4422020
ViatrisFor profit2012023
2 organizations
Page 1 / 1